Internal Medicine, Rheumatology · Brunswick, ME
NPI
1972768166
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
8 Mason Street
Brunswick, ME, 04011
Phone (072) 578-6608
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
627 services
Medicare patients, 2024
196
Average age 75
Drug cost, 2024
$2.2M
2,209 prescriptions
Company payments, 2025
$354
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Diana Vradii was code 99214 (office e&m - established), 286 times for 154 patients. In total Diana Vradii billed 627 services in 13 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 286 | 154 | $66.54 | $19K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 246 | 146 | $12.30 | $3,027 |
| 99213 Office E&M - Established | Office | 38 | 35 | $47.70 | $1,813 |
| 99215 Office E&M - Established | Office | 19 | 15 | $96.28 | $1,829 |
| 99204 Office E&M - New | Office | 16 | 16 | $93.27 | $1,492 |
By year: 2022 $25K for 360 services; 2023 $28K for 389 services; 2024 $29K for 627 services.
Medicare prescription drug claims, 2024
In 2024, the drug Diana Vradii prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 522 prescriptions and refills. In total Diana Vradii wrote 2,209 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 522 | 1,239 | 128 | $13K |
| Prednisone Generic | 315 | 474 | 95 | $1,792 |
| Hydroxychloroquine Sulfate Generic | 220 | 576 | 62 | $16K |
| Allopurinol Generic | 153 | 374 | 38 | $2,062 |
| Actemra Tocilizumab | 96 | 102 | Under 11 | $324K |
| Folic Acid Generic | 73 | 222 | 22 | $1,097 |
| Alendronate Sodium Generic | 58 | 127 | 17 | $584 |
| Enbrel Sureclick Etanercept | 55 | 56 | Under 11 | $403K |
| Humira(Cf) Pen Adalimumab | 37 | 41 | Under 11 | $312K |
| Tramadol Hcl Generic | 37 | 37 | Under 11 | $118 |
| Mycophenolate Mofetil Generic | 37 | 91 | 11 | $5,593 |
| Leflunomide Generic | 37 | 90 | 11 | $4,919 |
| Gabapentin Generic | 29 | 60 | Under 11 | $455 |
| Safetyglide Insulin Syringe Syringe And Needle,insulin,1ml | 27 | 71 | Under 11 | $172 |
| Oxycodone Hcl Generic | 24 | 24 | Under 11 | $204 |
Brand drugs: 427 claims; generic drugs: 1,741 claims; opioid claims: 75.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Diana Vradii $354 ($354 in general payments such as food, travel and fees) from 3 companies. The largest payer was Janssen Scientific Affairs, LLC with $136.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.